Article
The Benefit of Exercise in Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation
13 Mar 2019
Abstract excerpt
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) is increasingly used in the treatment of hematologic cancers such as leukemias, lymphomas, and myeloma, and for other hematologic disorders such as primary immunodeficiency, aplastic anemia, and myelodysplasia. Allo-HSCT entails a conditioning regimen of frequent high-dose chemotherapy in combination with total body irradiation, followed by infusion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
